Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jan 11, 2021
Date Accepted: Apr 13, 2021

The final, peer-reviewed published version of this preprint can be found here:

Effects of Providing Tailored Information About e-Cigarettes in a Web-Based Smoking Cessation Intervention: Protocol for a Randomized Controlled Trial

Elling JM, Crutzen R, Talhout R, de Vries H

Effects of Providing Tailored Information About e-Cigarettes in a Web-Based Smoking Cessation Intervention: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2021;10(5):e27088

DOI: 10.2196/27088

PMID: 33988520

PMCID: 8164120

Tailored Information about E-Cigarettes in a Web-Based Smoking Cessation Intervention: Study Protocol for a Randomized Controlled Trial

  • Jan Mathis Elling; 
  • Rik Crutzen; 
  • Reinskje Talhout; 
  • Hein de Vries

ABSTRACT

Background:

There is an ongoing debate whether or not electronic cigarettes (e-cigarettes) should be advocated for smoking cessation. Because of this uncertainty, information about the use of e-cigarettes for smoking cessation is usually not provided in governmental smoking cessation communications. However, there is an information need among smokers, because – despite this uncertainty – e-cigarettes are used by many smokers to reduce and/or quit tobacco smoking.

Objective:

To describe the study protocol of a Randomized Controlled Trial (RCT) to assess the effect of providing tailored information about e-cigarettes compared to not providing this information on determinants of decision-making and smoking reduction and abstinence. This information is provided in the context of a digital smoking cessation intervention.

Methods:

An RCT with a 6-month follow-up period will be conducted among adult smokers motivated to quit smoking within 5 years. Participants will be 1:1 randomized into either the intervention condition or control condition. Grounded on the I-Change Model, participants in both conditions will receive tailored feedback on attitude, social influence, preparatory plans, self-efficacy, and coping plans. Information on six clusters of smoking cessation methods will be provided in both conditions. Smokers in the intervention condition will also receive detailed tailored information on e-cigarettes; smokers in the control condition will not receive this information. The primary outcome measure will be the number of tobacco cigarettes smoked in the past 7 days. Secondary outcome measures will include 7-day point prevalence tobacco abstinence, 7-day point prevalence e-cigarette abstinence, and determinants of decision-making (i.e., knowledge and attitude regarding e-cigarettes). All outcomes will be self-assessed through web-based questionnaires.

Results:

Recruitment began in March 2020 and was completed by July 2020. We expect to publish the results in March 2021.

Conclusions:

The experimental design of the study allows conclusions to be formed regarding the effects of tailored information about e-cigarettes on decision-making and smoking behavior. The findings can inform the development of future smoking cessation interventions. Clinical Trial: Dutch Trial Register, Trial NL8330 (https://www.trialregister.nl/trial/8330)


 Citation

Please cite as:

Elling JM, Crutzen R, Talhout R, de Vries H

Effects of Providing Tailored Information About e-Cigarettes in a Web-Based Smoking Cessation Intervention: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2021;10(5):e27088

DOI: 10.2196/27088

PMID: 33988520

PMCID: 8164120

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.